# Automatic and standardized reporting of perioperative MRIs in patients with central nervous system tumors

**Authors:** David Bouget, Mathilde Gajda Faanes, Asgeir Store Jakola, Frederik Barkhof, Hilko Ardon, Lorenzo Bello, Mitchel S. Berger, Shawn L. Hervey-Jumper, Julia Furtner, Albert J. S. Idema, Barbara Kiesel, Georg Widhalm, Rishi Nandoe Tewarie, Emmanuel Mandonnet, Pierre A. Robe, Michiel Wagemakers, Timothy R. Smith, Philip C. De Witt Hamer, Ole Solheim, Ingerid Reinertsen

PMC · DOI: 10.3389/fneur.2025.1707481 · Frontiers in Neurology · 2026-02-06

## TL;DR

This paper introduces an automated pipeline for standardized postoperative MRI reporting in CNS tumor patients, using advanced models aligned with clinical guidelines.

## Contribution

A novel automated pipeline for postoperative CNS tumor MRI reporting, integrating segmentation and classification models aligned with RANO 2.0 guidelines.

## Key findings

- Segmentation models achieved high Dice scores for tumor core and resection cavity.
- MR sequence classification reached 99.5% balanced accuracy using DenseNet.
- The pipeline is integrated into the Raidionics platform for clinical use.

## Abstract

Magnetic resonance (MR) imaging is essential for diagnosing central nervous system (CNS) tumors, guiding surgical planning, treatment decisions, and assessing postoperative outcomes and complications. While recent work has advanced automated tumor segmentation and report generation, most efforts have focused on preoperative data, with limited attention to postoperative imaging analysis.

This study introduces a comprehensive pipeline for standardized postsurgical reporting in CNS tumors. Using the Attention U-Net architecture, segmentation models were trained, independently targeting the preoperative tumor core, non-enhancing tumor core, postoperative contrast-enhancing residual tumor, and resection cavity. In the process, the influence of varying MR sequence combinations was assessed. Additionally, MR sequence classification and tumor type identification for contrast-enhancing lesions were explored using the DenseNet architecture. The models were integrated seamlessly into an automated and standardized reporting pipeline, following the RANO 2.0 guidelines. Training was conducted on multicentric datasets comprising 2000 to 7000 patients, incorporating both private and public data, using a 5-fold cross-validation.

Evaluation included patient-, voxel-, and object-wise metrics, with benchmarking against the latest BraTS challenge results. The segmentation models achieved average voxel-wise Dice scores of 87%, 66%, 70%, and 77% for the tumor core, non-enhancing tumor core, contrast-enhancing residual tumor, and resection cavity, respectively. Classification models reached 99.5% balanced accuracy in MR sequence classification and 80% in tumor type classification.

The pipeline presented in this study enables robust, automated segmentation, MR sequence classification, and standardized report generation aligned with RANO 2.0 guidelines, enhancing postoperative evaluation and clinical decision-making. The proposed models and methods were integrated into Raidionics, open-source software platform for CNS tumor analysis, now including a dedicated module for postsurgical analysis.

## Full-text entities

- **Diseases:** MEN (MESH:D008579), MET (MESH:D009362), CNS tumor (MESH:D016543), TS (MESH:D005879), Primary (MESH:D010538), infarction (MESH:D007238), glioblastoma (MESH:D005909), cysts (MESH:D003560), TC (OMIM:275350), BraTS (MESH:D001932), necrosis (MESH:D009336), PD (MESH:D010300), GLI (MESH:D005910), CNS (MESH:D002493), neurological and cognitive decline (MESH:D060825), Tumor (MESH:D009369), ET (MESH:C564835), contrast (MESH:D005119), hemorrhage (MESH:D006470)
- **Chemicals:** SUH (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** SH — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_W974)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920189/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12920189/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920189/full.md

---
Source: https://tomesphere.com/paper/PMC12920189